ClinicalTrials.Veeva

Menu

The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19

G

Guangzhou Medical University

Status

Completed

Conditions

Coronavirus Disease 2019
Character of the Severe Patients

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04403009
YLS2020(112)

Details and patient eligibility

About

To investigate the difference of the difference between the nonfatal Coronavirus Disease 2019 (COVID-19) Patients and the fatal Patients .The cross sectional study was undertaken to compare the clinical information (laboratory and radiologic characteristics)of nonfatal participants and fatal cases. The investigators wish figure out the clinical character of the fatal participants. The result may help the physician to find the fatal patients with COVID-19 more easily. The fatal patients with COVID-19 could be treated early.

Enrollment

100 patients

Sex

All

Ages

20 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patients with Coronavirus Disease 2019
  • Positive result on real-time reverse-transcriptase-polymerase-chain-reaction
  • Positive result on chest computed tomography

Exclusion criteria

  • No

Trial design

100 participants in 2 patient groups

the nonsevere Coronavirus Disease 2019 Patients
Treatment:
Other: no intervention
the severe Coronavirus Disease 2019 Patients
Treatment:
Other: no intervention

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems